Howland Capital Management LLC Has $20.96 Million Holdings in Celgene Co. (CELG)

Grimes invested in 1,614 shares or 0.02% of the stock. The shares were sold at an average price of $95.99, for a total transaction of $887,907.50. BioScrip, Inc. (NASDAQ:BIOS) has declined 29.17% since March 9, 2017 and is downtrending. It has underperformed by 8.03% the S&P500.

Nbt Bank N A increased its stake in Celgene Corp (CELG) by 11.9% based on its latest 2017Q3 regulatory filing with the SEC. C M Bidwell & Associates Ltd sold 35,225 shares as Celgene Corp (CELG)'s stock declined 3.49%. The hedge fund run by Panayotis Takis Sparaggis held 1.78 million shares of the major pharmaceuticals company at the end of 2017Q3, valued at $258.98M, up from 1.77M at the end of the previous reported quarter. The stock increased 1.08% or $0.97 during the last trading session, reaching $91.19. Parsley Energy, Inc. (NYSE:PE) has risen 26.09% since March 11, 2017 and is uptrending. It has outperformed by 10.25% the S&P500. About 1.69M shares traded. It also increased its holding in Sarepta Therapeutics Inc (NASDAQ:SRPT) by 100,000 shares in the quarter, for a total of 1.40M shares, and has risen its stake in Spdr S&P 500 Etf Trust (Put) (SPY).

Investors sentiment decreased to 0.83 in Q3 2017. The stock has a market capitalization of $70,660.00, a price-to-earnings ratio of 17.63, a PEG ratio of 0.64 and a beta of 1.58. Eagleclaw Cap Managment Lc invested in 0.94% or 11,360 shares.

A number of other hedge funds have also added to or reduced their stakes in CELG. 261.70 million shares or 0.63% less from 263.35 million shares in 2017Q2 were reported. Pointstate Capital Lp has 2.79 million shares for 0.69% of their portfolio. (NASDAQ:CBF) for 389,220 shares. Clarivest Asset Mgmt Limited Co invested in 16,292 shares or 0.01% of the stock. C M Bidwell And Ltd, Hawaii-based fund reported 2,535 shares. The company had a trading volume of 5,996,611 shares, compared to its average volume of 7,800,000. Blackrock invested 0% in BioScrip, Inc. Fukoku Mutual Life Insurance Co invested in 3,600 shares or 0.03% of the stock. Tower Rech Limited Liability Co (Trc) invested in 0% or 8,089 shares. Mu Invs Co holds 220 shares or 0.02% of its portfolio. California Pub Employees Retirement System holds 53,717 shares or 0% of its portfolio. Lombard Odier Asset (Usa) Corp stated it has 0.01% in BioScrip, Inc. Ellington Management Lc invested 0.17% in Leucadia National Corporation (NYSE:LUK). Schroder Management Group Incorporated has invested 0.04% in International Paper Company (NYSE:IP).

COPYRIGHT VIOLATION WARNING: "BMO Capital Markets Lowers Celgene (NASDAQ:CELG) Price Target to $139.00" was first published by Enterprise Leader and is the sole property of of Enterprise Leader. The rating was maintained by Stifel Nicolaus on Tuesday, February 7 with "Buy". Therefore 81% are positive. Wayfair LLC had 87 analyst reports since July 31, 2015 according to SRatingsIntel. The company was maintained on Thursday, June 1 by Mizuho. Jefferies maintained International Paper Company (NYSE:IP) rating on Wednesday, August 16. Celgene has a consensus rating of "Buy" and an average target price of $128.22. The stock of Stoneridge, Inc. Cowen & Co maintained the shares of CELG in report on Thursday, July 27 with "Buy" rating. Jefferies has "Buy" rating and $4.0 target. FBR Capital downgraded the stock to "Mkt Perform" rating in Wednesday, June 8 report. The company was upgraded on Thursday, August 10 by SunTrust. Finally, Leerink Swann reiterated a buy rating and issued a $120.00 price objective on shares of Celgene in a research report on Wednesday, December 13th.

Celgene (NASDAQ:CELG)'s stock had its "buy" rating restated by Cann in a research report issued to clients and investors on Thursday, February 15th. The company's revenue for the quarter was up 16.9% compared to the same quarter a year ago. After $1.87 actual earnings per share reported by Celgene Corporation for the previous quarter, Wall Street now forecasts -4.81% negative EPS growth.

Wexford Capital Lp, which manages about $6.34 billion and $1.17B US Long portfolio, decreased its stake in Ishares Tr (EEM) by 119,832 shares to 702,231 shares, valued at $31.47M in 2017Q3, according to the filing. The C M Bidwell & Associates Ltd holds 2,535 shares with $370,000 value, down from 37,760 last quarter.

Investors sentiment decreased to 1.17 in 2017 Q3. Its down 0.03, from 0.91 in 2017Q2. It is negative, as 37 investors sold IP shares while 252 reduced holdings. The biopharmaceutical company reported $1.87 earnings per share for the quarter, topping the Zacks' consensus estimate of $1.78 by $0.09. Swiss Comml Bank owns 49,800 shares or 0% of their United States portfolio. Smith Asset Group Lp holds 470,952 shares or 2.29% of its portfolio.




Analysts await Celgene Corporation (NASDAQ:CELG) to report earnings on April, 26.

Shares of Celgene Co. Bb&T holds 23,369 shares. 4,161 were accumulated by Charter Tru Company. Horseman Mngmt Ltd holds 6,000 shares.

Shares of Celgene Co. Amalgamated Fincl Bank stated it has 93,591 shares. Holderness, a North Carolina-based fund reported 12,166 shares. Highstreet Asset Management invested 0.15% of its portfolio in Celgene Corporation (NASDAQ:CELG). 188,100 were accumulated by Duquesne Family Office Limited. River Mercantile Asset Mngmt Ltd Liability Partnership has 0.41% invested in Leucadia National Corporation (NYSE:LUK).

Among 34 analysts covering Celgene Corporation (NASDAQ:CELG), 19 have Buy rating, 2 Sell and 13 Hold. Therefore 33% are positive. Celgene Corporation had 138 analyst reports since July 21, 2015 according to SRatingsIntel. The stock has "Buy" rating by Suntrust Robinson on Thursday, January 7. The firm has "Buy" rating given on Friday, February 24 by Brean Capital. William Blair reaffirmed a "buy" rating on shares of Celgene in a research report on Wednesday, February 28th. The rating was maintained by RBC Capital Markets with "Buy" on Tuesday, January 23.

Several equities research analysts recently commented on the company. The firm has "Hold" rating by Brean Capital given on Wednesday, August 2. Barclays Capital maintained Celgene Corporation (NASDAQ:CELG) rating on Friday, October 13. Artemis Invest Mgmt Limited Liability Partnership reported 0.45% in Celgene Corporation (NASDAQ:CELG).

Celgene Co. (NASDAQ:CELG) Director Gilla Kaplan sold 9,250 shares of Celgene stock in a transaction on Tuesday, February 20th.

Since September 12, 2017, it had 1 insider buy, and 3 sales for $2.98 million activity.

In related news, Director Ernest Mario sold 13,370 shares of the stock in a transaction dated Friday, February 23rd. Shares for $248,498 were sold by Curran Terrie on Monday, September 25.

Latest News